(Q46058167)

19 December 2017

title

High-dose selective serotonin reuptake inhibitors in OCD: a systematic retrospective case notes survey (English)

1 reference

19 December 2017

0 references

I Pampaloni

1

1 reference

19 December 2017

T Sivakumaran

2

1 reference

19 December 2017

C J Hawley

3

1 reference

19 December 2017

A Al Allaq

4

1 reference

19 December 2017

J Farrow

5

1 reference

19 December 2017

S Nelson

6

1 reference

19 December 2017

N A Fineberg

7

1 reference

19 December 2017

language of work or name

English

0 references

publication date

7 April 2009

1 reference

19 December 2017

Journal of Psychopharmacology

published in

1 reference

19 December 2017

volume

24

1 reference

19 December 2017

page(s)

1439-1445

1 reference

19 December 2017

issue

10

1 reference

19 December 2017

Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881109104850

Response to high doses of citalopram in treatment-resistant obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109104850

A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109104850

Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109104850

Mechanisms of action of current and potential pharmacotherapies of obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109104850

Adjunctive quetiapine for serotonin reuptake inhibitor-resistant obsessive-compulsive disorder: a meta-analysis of randomized controlled treatment trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109104850

Escitalopram prevents relapse of obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109104850

Outcome and prognostic factors in infantile autism and similar conditions: a population-based study of 46 cases followed through puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109104850

Serotoninergic mechanisms in the treatment of obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109104850

The Yale-Brown Obsessive Compulsive Scale. II. Validity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109104850

Occupancy of brain serotonin transporters during treatment with paroxetine in patients with social phobia: a positron emission tomography study with 11C McN 5652.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109104850

Treatment non-response in OCD: methodological issues and operational definitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109104850

High-dose escitalopram for the treatment of obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109104850

Antipsychotic augmentation of serotonergic antidepressants in treatment-resistant obsessive-compulsive disorder: a meta-analysis of the randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109104850

Escitalopram in obsessive–compulsive disorder: a randomized, placebo-controlled, paroxetine-referenced, fixed-dose, 24-week study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109104850

Seizure disorders in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109104850

Corelease of dopamine and serotonin from striatal dopamine terminals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109104850

High doses of sertraline for treatment-resistant obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109104850

21 January 2018

Identifiers

DOI

10.1177/0269881109104850

1 reference

19 December 2017

PubMed ID

19351803

1 reference

19 December 2017